Sökning: WFRF:(Wallon D.)
> (2015-2019) >
Infliximab restores...
Infliximab restores colonic barrier to adherent-invasive E. coli in Crohn's disease via effects on epithelial lipid rafts
-
- Yakymenko, Olena, 1988- (författare)
- Linköpings universitet,Avdelningen för Kirurgi, Ortopedi och Onkologi,Medicinska fakulteten,Department of Surgery and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden
-
- Schoultz, Ida, 1979- (författare)
- Örebro universitet,Institutionen för medicinska vetenskaper,Department of Medical Sciences, Faculty of Health and Medicine, Örebro University, Örebro, Sweden
-
- Gullberg, Elisabet, 1972- (författare)
- Linköpings universitet,Medicinska fakulteten,Institutionen för klinisk och experimentell medicin,Region Östergötland, Kirurgiska kliniken US,Department of Surgery and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden
-
visa fler...
-
- Ström, Magnus, 1945- (författare)
- Linköpings universitet,Avdelningen för neuro- och inflammationsvetenskap,Medicinska fakulteten,Region Östergötland, Magtarmmedicinska kliniken,Department of Gastroenterology and Hepatology, Linköping University, Linköping, Sweden
-
- Almer, Sven (författare)
- Karolinska Institutet,Department of Medicine, Karolinska Institutet, Stockholm, Sweden / GastroCentrum, Karolinska University Hospital, Stockholm, Sweden
-
- Wallon, Conny, 1966- (författare)
- Linköpings universitet,Avdelningen för Kirurgi, Ortopedi och Onkologi,Medicinska fakulteten,Region Östergötland, Kirurgiska kliniken US,Department of Surgery and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden
-
- Wang, Arthur (författare)
- Gastrointestinal Research Group, Cumming School of Medicine, University of Calgary, Calgary, Canada.
-
- Keita, Åsa, 1973- (författare)
- Linköpings universitet,Avdelningen för Kirurgi, Ortopedi och Onkologi,Medicinska fakulteten,Region Östergötland, Kirurgiska kliniken US,Department of Surgery and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden
-
- Campbell, Barry J. (författare)
- Gastroenterology Research Unit, Department of Cellular and Molecular Physiology, University of Liverpool, Liverpool, UK
-
- McKay, Derek M. (författare)
- Gastrointestinal Research Group, Cumming School of Medicine, University of Calgary, Calgary, Canada
-
- Söderholm, Johan D, 1958- (författare)
- Linköpings universitet,Avdelningen för Kirurgi, Ortopedi och Onkologi,Medicinska fakulteten,Region Östergötland, Kirurgiska kliniken US,Department of Surgery and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden
-
visa färre...
-
(creator_code:org_t)
- 2018-04-24
- 2018
- Engelska.
-
Ingår i: Scandinavian Journal of Gastroenterology. - Oxfordshire, United Kingdom : Taylor & Francis. - 0036-5521 .- 1502-7708. ; 53:6, s. 677-684
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://www.tandfonl...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
https://urn.kb.se/re...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Objective: Infliximab is important in the therapeutic arsenal of Crohn’s disease (CD). However, its effect on mucosal barrier function is not fully understood. Adherent-invasive Escherichia coli (AIEC) are important in CD pathophysiology, but the transmucosal uptake routes are partly unknown. We investigated effects of infliximab on uptake of colon-specific AIEC HM427 across CD colonic mucosa.Materials and methods: Endoscopic biopsies from non-inflamed colon of seven patients with CD, before and after two infliximab infusions, and eight non-inflammation controls, were mounted in Ussing chambers. Paracellular permeability (51Cr-EDTA) and transmucosal passage of GFP-expressing HM427 were studied. Mechanisms of HM427 transepithelial transport were investigated in Caco-2 monolayers treated with TNF, in the presence of infliximab and/or endocytosis inhibitors.Results: Before infliximab treatment, colonic passage of HM427 [CD: 2475 CFU (450–3000); controls 1163(225–1950)] and 51Cr-EDTA permeability were increased in CD (p < .05), but were restored to control levels by infliximab (CD: 150 (18.8–1069)). In TNF-exposed Caco-2 monolayers HM427 transport and lipid rafts/HM427 co-localization was decreased by infliximab. The lipid raft inhibitor methyl-β-cyclodextrin decreased HM427 transport.Conclusion: Infliximab restored the colonic barrier to AIEC in CD; an effect partially mediated by blocking lipid rafts in epithelial cells. This ability likely contributes to infliximab’s clinical efficacy in colonic CD.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Gastroenterologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Gastroenterology and Hepatology (hsv//eng)
Nyckelord
- Inflammatory bowel disease
- microbiology
- large intestine
- intestinal barrier function
- adherent invasive E. coli
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Yakymenko, Olena ...
-
Schoultz, Ida, 1 ...
-
Gullberg, Elisab ...
-
Ström, Magnus, 1 ...
-
Almer, Sven
-
Wallon, Conny, 1 ...
-
visa fler...
-
Wang, Arthur
-
Keita, Åsa, 1973 ...
-
Campbell, Barry ...
-
McKay, Derek M.
-
Söderholm, Johan ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Gastroenterologi
- Artiklar i publikationen
-
Scandinavian Jou ...
- Av lärosätet
-
Linköpings universitet
-
Örebro universitet
-
Karolinska Institutet